ArticleFrontiers in oncology2020

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells.

Yi-Dong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.